Endocrine Biochemical Testing: Principles, Analytical Methods, and Laboratory Evaluation of Hormones

Endocrine biochemical testing is a specialized laboratory discipline that quantifies hormones, hormone precursors, metabolites, and related autoantibodies in biological specimens to assess the function of endocrine glands and hormonal regulatory axes. This technical article presents the sample types, analyte panels, analytical platforms, quality standards, and application scenarios associated with hormone measurement. The content is intended for clinicians, laboratory scientists, pharmaceutical researchers, and organizations seeking accredited third-party laboratory support for endocrine studies.

Technical Overview

Endocrine biochemical testing encompasses the quantitative and qualitative analysis of circulating hormones, steroid precursors, hormone metabolites, binding proteins, and organ-specific autoantibodies in order to evaluate the secretory function of endocrine glands. Because hormones typically circulate at picomolar to nanomolar concentrations and exert profound physiological effects, the analytical systems used for this purpose must deliver high sensitivity, high specificity, and strict pre-analytical control.

From a biochemical standpoint, the analytes fall into three major classes:

• Peptide and protein hormones, such as insulin, growth hormone (GH), thyroid-stimulating hormone (TSH), adrenocorticotropic hormone (ACTH), and the gonadotropins LH and FSH, which are measured primarily by immunometric techniques.
• Steroid hormones derived from cholesterol, such as cortisol, aldosterone, testosterone, estradiol, and progesterone, which are well suited to both immunoassay and mass spectrometric quantification.
• Amine hormones, including the iodinated thyroid hormones (T4, T3) and catecholamines (epinephrine, norepinephrine, dopamine), which require method selection based on concentration range and matrix.

Clinical interpretation relies on an understanding of the hypothalamic–pituitary–target gland feedback axes, including the hypothalamic–pituitary–thyroid (HPT), hypothalamic–pituitary–adrenal (HPA), and hypothalamic–pituitary–gonadal (HPG) axes, as well as the GH/IGF-1 axis. Testing distinguishes hyperfunction from hypofunction, helps localize the lesion to the pituitary or the peripheral gland through paired stimulatory and target hormone measurements, and supports long-term therapeutic drug monitoring.

Testing Samples

Serum and Plasma

Venous blood collected into serum separator tubes or anticoagulant tubes is the primary matrix for thyroid, reproductive, adrenal, pituitary, and glycometabolic panels. Certain analytes impose special requirements: ACTH must be collected into pre-chilled EDTA tubes, separated rapidly, and frozen to prevent proteolytic degradation, while renin and aldosterone studies require posture-controlled sampling (supine or upright) and defined timing.

24-Hour Urine

Complete 24-hour urine collections integrate hormone secretion over a full circadian cycle and are preferred for urinary free cortisol, fractionated metanephrines and catecholamines, 17-ketosteroids, and 5-hydroxyindoleacetic acid (5-HIAA). Appropriate preservatives, such as hydrochloric acid or boric acid, and verification of collection completeness through creatinine measurement are essential pre-analytical safeguards.

Saliva

Salivary measurement reflects the free, biologically active fraction of steroid hormones and permits non-invasive, stress-free sampling. Late-night salivary cortisol is a widely accepted screening test for cortisol hypersecretion, and salivary steroid profiles are valuable in pediatric and repeated-sampling study designs.

Dried Blood Spots

Capillary blood spotted onto filter paper is the standard matrix for newborn screening programs, including TSH-based detection of congenital hypothyroidism and 17-hydroxyprogesterone-based detection of congenital adrenal hyperplasia, and is increasingly used in population biomonitoring studies.

Pre-analytical Considerations

Hormone results are strongly influenced by biological context. Key variables include:

• Circadian timing: cortisol peaks in the early morning and reaches a nadir near midnight.
• Fasting status: glucose, insulin, and C-peptide interpretation requires standardized fasting conditions.
• Menstrual cycle phase and menopausal status: essential for interpreting LH, FSH, estradiol, and progesterone.
• Medication effects: high-dose biotin, glucocorticoids, dopamine agonists, thyroid hormone preparations, and estrogen-containing contraceptives can materially alter results.
• Stress, posture, and acute illness, which affect the HPA axis and catecholamine release.

Testing Items

Typical endocrine panels are organized by functional axis and clinical indication. Core analyte groups include:

Thyroid Function Panel

• TSH (third- or fourth-generation high-sensitivity assays), free T4, free T3, and total T3/T4.
• Reverse T3 and thyroglobulin for selected indications.
• Autoantibodies: anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin, and TSH receptor antibodies (TRAb).

Adrenal Axis Markers

• Serum cortisol (morning, evening, or midnight) and plasma ACTH.
• Aldosterone and direct renin concentration or plasma renin activity for primary aldosteronism screening.
• Dehydroepiandrosterone sulfate (DHEA-S), 17-hydroxyprogesterone, and 11-deoxycortisol for steroidogenesis evaluation.
• Plasma or urinary fractionated metanephrines and catecholamines for pheochromocytoma and paraganglioma work-up.

Reproductive Hormone Panel

• LH, FSH, estradiol, and progesterone for cycle monitoring and assisted reproduction support.
• Total and free testosterone, SHBG, and the free androgen index for hyperandrogenism evaluation.
• Prolactin, anti-Müllerian hormone (AMH), inhibin B, and hCG.

Growth, Pituitary, and Glycometabolic Markers

• GH and IGF-1 (with IGFBP-3 where indicated) for growth disorders and acromegaly.
• Fasting glucose, insulin, C-peptide, and HbA1c for diabetes classification and beta-cell function assessment.
• Diabetes-related autoantibodies: GAD65, IA-2, ZnT8, and insulin autoantibodies.
• Vasopressin (ADH) and osmolality pairing for water homeostasis disorders.

Bone and Calcium Metabolism Markers

• PTH, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D.
• Calcium, phosphorus, magnesium, and albumin-corrected calcium.
• Bone turnover markers such as osteocalcin, P1NP, and beta-CTX.

Dynamic Function Testing

Stimulation and suppression protocols, including the ACTH stimulation test, dexamethasone suppression test, oral glucose tolerance test with GH sampling, and insulin tolerance test, extend static measurements into a functional assessment of glandular reserve and feedback integrity.

Testing Methods

Immunoassay Platforms

Automated chemiluminescent immunoassay (CLIA) and electrochemiluminescent immunoassay (ECLIA) platforms are the mainstay of routine endocrine testing, offering sandwich formats for large peptide antigens and competitive formats for small steroid molecules. Enzyme-linked immunosorbent assay (ELISA) remains widely used in research settings, while classic radioimmunoassay (RIA) is largely of historical interest. Analytical interferences such as heterophile antibodies, the high-dose hook effect, and biotin interference in streptavidin-based systems must be systematically evaluated and mitigated.

Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)

LC-MS/MS has become the reference-grade methodology for steroid hormone quantification, enabling multiplexed panels (for example, cortisol, cortisone, 11-deoxycortisol, and androgens in a single run) with superior specificity compared with antibody-based cross-reactivity. Gas chromatography–mass spectrometry (GC-MS) continues to be applied to comprehensive urinary steroid profiling. Bioanalytical method validation should follow ICH M10 and applicable regulatory bioanalytical guidance.

Enzymatic, Electrophoretic, and Chromatographic Methods

Hexokinase or glucose oxidase methods are reference-aligned for glucose, ion-exchange HPLC and capillary electrophoresis serve as traceable approaches for HbA1c, and isotope dilution techniques underpin higher-order reference measurement procedures for creatinine and other supporting analytes.

Quality Assurance and Standardization

• Laboratory accreditation to ISO 15189 for medical laboratories, or ISO/IEC 17025 for research and contract testing activities.
• Method evaluation aligned with CLSI protocols, including EP05 for precision, EP06 for linearity, EP17 for detection capability, and EP28 for reference interval establishment.
• Calibration traceability to higher-order reference materials and procedures consistent with ISO 17511.
• Participation in external quality assessment (proficiency testing) schemes and lot-to-lot verification of reagents.
• Documented pre-analytical instructions, result verification rules, and reflex testing algorithms.

Applications

Clinical Diagnosis and Monitoring

Endocrine biochemical testing underpins the diagnosis and management of diabetes mellitus and its complications, hypo- and hyperthyroidism, polycystic ovary syndrome, infertility and reproductive endocrine dysfunction, Cushing syndrome and adrenal insufficiency, primary aldosteronism, pheochromocytoma, growth hormone disorders, osteoporosis and metabolic bone disease, and inborn errors identified through newborn screening.

Pharmaceutical Research and Drug Development

Hormonal biomarkers are integral to endocrine safety pharmacology and general repeat-dose toxicology, including HPA axis suppression assessment for inhaled and topical corticosteroids, thyroid function surveillance, and reproductive hormone monitoring in developmental and reproductive toxicology studies. Validated LC-MS/MS and ligand-binding assays support regulated bioanalysis of endogenous biomarkers throughout clinical development.

Occupational and Environmental Health

Biomonitoring of thyroid, adrenal, and reproductive hormones is applied in studies of populations exposed to endocrine-disrupting chemicals and in occupational health surveillance programs, complementing analytical testing of the chemicals themselves according to recognized standard methods.

Sports Science and Anti-Doping

Steroid and gonadotropin profiling, including testosterone/epitestosterone ratio assessment and longitudinal LH/FSH monitoring under World Anti-Doping Code-aligned laboratory programs, contributes to the detection of exogenous hormone administration.

Public Health and Food Safety

Endocrine testing supports population nutrition surveys (for example, vitamin D status mapping), epidemiological research, and surveillance programs for hormonally active residues in food-producing animals.

FAQ

Why do cortisol tests need to be drawn at specific times of day?

Cortisol secretion follows a pronounced circadian rhythm, with peak levels in the early morning and a nadir around midnight. Diagnostic thresholds for hypercortisolism and adrenal insufficiency are time-of-day specific, so collection timing is part of the test definition rather than a preference.

Can supplements or medications interfere with hormone test results?

Yes. High-dose biotin can cause falsely elevated or falsely lowered results in biotin–streptavidin-based immunoassays, estrogens increase SHBG and alter free hormone interpretation, glucocorticoids suppress the HPA axis, and thyroid hormone preparations directly change thyroid panel results. Declaring all supplements and medications before sampling is strongly advised.

What is the difference between total and free hormone measurement?

Total hormone assays measure both the protein-bound and the unbound (free) fraction, whereas free hormone measurements or free hormone estimates (for example, free testosterone calculated from total testosterone and SHBG) approximate the biologically active concentration. Free measurements are preferred when binding protein levels are abnormal, such as in pregnancy, obesity, or estrogen therapy.

Why is LC-MS/MS increasingly preferred for steroid hormones?

Immunoassays for steroids can suffer from antibody cross-reactivity with structurally related compounds, particularly at low concentrations. LC-MS/MS provides chromatographic separation, structural confirmation, and multiplexed quantification with greater analytical specificity, which is critical for pediatric samples, low-concentration analytes, and comprehensive steroid panels.

How quickly are results available?

Automated immunoassay and chemistry analytes are typically reported within 24 hours of receipt, while LC-MS/MS panels, dynamic function tests requiring serial sampling, and send-out reference procedures may require several working days. Accredited third-party laboratories should provide documented turnaround commitments and critical value notification procedures.

How should a testing laboratory be selected?

Selection criteria should include ISO 15189 or ISO/IEC 17025 accreditation status, participation in relevant external quality assessment schemes, demonstrated method validation records, traceability of calibrators, availability of age- and sex-specific reference intervals, and documented management of pre-analytical instructions and interferences.